<?xml version="1.0" encoding="UTF-8"?>
<p>The expanding popularity of MR has facilitated its critical evaluation and steady improvement (
 <xref rid="fcaa031-B18" ref-type="bibr">Burgess 
  <italic>et al.</italic>, 2015
 </xref>, 
 <xref rid="fcaa031-B17" ref-type="bibr">2018</xref>; 
 <xref rid="fcaa031-B44" ref-type="bibr">Holmes 
  <italic>et al.</italic>, 2017
 </xref>; 
 <xref rid="fcaa031-B43" ref-type="bibr">Hemani 
  <italic>et al.</italic>, 2018
 </xref>), and initiatives such as the UK Biobank, Million Veterans Program and 23andMe (
 <ext-link ext-link-type="uri" xlink:href="https://research.23andme.com/" xmlns:xlink="http://www.w3.org/1999/xlink">https://research.23andme.com/, last accessed 9 April 2020</ext-link>) provide genetic data for a wealth of phenotypic traits (
 <xref rid="fcaa031-B34" ref-type="bibr">Gaziano 
  <italic>et al.</italic>, 2016
 </xref>; 
 <xref rid="fcaa031-B19" ref-type="bibr">Bycroft 
  <italic>et al.</italic>, 2018
 </xref>). In addition, guidelines have been produced to standardize the reporting quality of MR studies (
 <xref rid="fcaa031-B15" ref-type="bibr">Burgess 
  <italic>et al</italic>., 2019
 </xref>, 
 <xref rid="fcaa031-B22" ref-type="bibr">Davey Smith 
  <italic>et al.</italic>, 2019
 </xref>).
</p>
